+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Heparin cofactor II thrombin complex as a biomarker for mucopolysaccharidosis: Indian experience

Heparin cofactor II thrombin complex as a biomarker for mucopolysaccharidosis: Indian experience

Indian Pediatrics 51(2): 128-130

Serum heparin cofactor II-thrombin complex (HCII-T) is an emerging biomarker for mucopolysaccharidosis disease (MPS I and MPS II). Seventeen cases (6 MPS I and 11 MPS II) and sixty healthy controls were enrolled in study, conducted from September 2008 to December 2012. The mean ± SD age of MPS1 (n=6, 5 males) and MPS II was 7.02 ± 3.25 and 5.2 ± 2.15 years, respectively. Disease status was confirmed by clinical features and enzyme assay. Urinary glycosaminoglycans were measured in spot urine samples and expressed in relation to creatinine content. HCIIT measurement was done using sandwich ELISA at enrolment and after 12 and 24 months of recruitment. Urinary glycosaminoglycans and HCIIT were elevated in all patients compared to their healthy controls. Both markers could not discriminate between the type of mucopolysaccharidosis. Heparin Cofactor II Thrombin Complex is a good biomarker for mucopolysaccharidosis I and II.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 053513060

Download citation: RISBibTeXText

PMID: 24277967

DOI: 10.1007/s13312-014-0344-9

Related references

Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice. Molecular Genetics and Metabolism 99(3): 269-274, 2010

Longitudinal observations of serum heparin cofactor II-thrombin complex in treated Mucopolysaccharidosis I and II patients. Journal of Inherited Metabolic Disease 35(2): 355-362, 2012

Heparin cofactor II-thrombin complex in MPS I: a biomarker of MPS disease. Molecular Genetics and Metabolism 88(3): 235-243, 2006

Heparin cofactor II-thrombin complex: a biomarker of MPS disease. Molecular Genetics and Metabolism 94(4): 456-461, 2008

Heparin cofactor II-thrombin complex as an MPS disease biomarker: Are. 2007

Plasma levels of heparin cofactor II and thrombin-heparin cofactor II complex in patients with disseminated intravascular coagulation. Blood 98(11 Part 2): 85b, November 16, 2001

Modulation of heparin cofactor II function by S protein (vitronectin) and formation of a ternary S protein-thrombin-heparin cofactor II complex. Thrombosis and Haemostasis 60(3): 399-406, 1988

A catalytic role for heparin. Evidence for a ternary complex of heparin cofactor thrombin and heparin. Biochimica et Biophysica Acta 535(1): 66-77, 1978

Ligand binding to thrombin exosite II induces dissociation of the thrombin-heparin cofactor II(L444R) complex. Biochemistry 37(9): 3203-3209, 1998

Fluorescent reporters of thrombin, heparin cofactor II, and heparin binding in a ternary complex. Analytical Biochemistry 421(2): 489-498, 2012

Formation of a ternary complex of heparin cofactor thrombin and heparin. Lundblad, Roger L , John W Fenton, Ii And Kenneth G Mann (Ed ) Chemistry And Biology Of Thrombin Proceedings Of A Conference Rochester, Minn , Usa, March 31-April 1, Xii+564p Illus Ann Arbor Science Publishers, Inc: Ann Arbor, Mich , Usa ISBN 0-250-40160-6: 395-401, 1977

Thrombin inhibition by antithrombin iii and heparin cofactor ii in the presence of heparin improved purification of heparin cofactor ii. Blut 49(2): 131, 1984

Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin. Blood 85(6): 1527-1534, 1995

Prevention of thrombus formation and growth by antithrombin III and heparin cofactor II-dependent thrombin inhibitors: Importance of heparin cofactor II. Thrombosis Research 74(5): 463-475, 1994

Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity. Journal of Biological Chemistry 268(5): 3639-3645, 1993